Compile Data Set for Download or QSAR
Report error Found 468 Enz. Inhib. hit(s) with all data for entry = 2812
TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381082BDBM381082(US9890185, Example 38(e))
Affinity DataIC50: 5nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381166BDBM381166(US9890185, Example 79(g))
Affinity DataIC50: 5nMAssay Description:Method 2: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381094BDBM381094(US9890185, Example 38(q))
Affinity DataIC50: 6nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381167BDBM381167(US9890185, Example 79(m))
Affinity DataIC50: 6nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381071BDBM381071(1-(5-(tert-Butyl)-3-(dimethylphosphoryl)-2-methoxy...)
Affinity DataIC50: 6nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381167BDBM381167(US9890185, Example 79(m))
Affinity DataIC50: 7nMAssay Description:Method 2: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381123BDBM381123(1-(5-(tert-Butyl)-2-methoxy-3-(methylsulfinyl)phen...)
Affinity DataIC50: 8nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381092BDBM381092(US9890185, Example 38(o))
Affinity DataIC50: 9nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 380997BDBM380997(US9890185, Example 1)
Affinity DataIC50: 9nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381084BDBM381084(US9890185, Example 38(g))
Affinity DataIC50: 9nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 380998BDBM380998(1-(5-(tert-Butyl)-3-(dimethylphosphoryl)-2-methoxy...)
Affinity DataIC50: 11nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381150BDBM381150(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Affinity DataIC50: 12nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381126BDBM381126(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 12nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381134BDBM381134(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 12nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381080BDBM381080(US9890185, Example 38(c))
Affinity DataIC50: 12nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381081BDBM381081(US9890185, Example 38(d))
Affinity DataIC50: 13nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381098BDBM381098(US9890185, Example 38(u))
Affinity DataIC50: 13nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381149BDBM381149(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 13nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381004BDBM381004(5-(tert-Butyl)-2-methoxy-3-(3-(4-((2-((3-methoxy-5...)
Affinity DataIC50: 14nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381012BDBM381012(US9890185, Example 15(b))
Affinity DataIC50: 14nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381152BDBM381152(3-((4-((4-(3-(3-(Acetamidomethyl)-5-(tert-butyl)-2...)
Affinity DataIC50: 14nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381098BDBM381098(US9890185, Example 38(u))
Affinity DataIC50: 15nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381146BDBM381146(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 15nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381057BDBM381057(1-(5-(tert-Butyl)-3-(dimethylphosphoryl)-2-methoxy...)
Affinity DataIC50: 15nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381102BDBM381102(US9890185, Example 38(y))
Affinity DataIC50: 15nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381150BDBM381150(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Affinity DataIC50: 16nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381013BDBM381013(US9890185, Example 15(c))
Affinity DataIC50: 16nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381020BDBM381020(US9890185, Example 15(j))
Affinity DataIC50: 16nMAssay Description:Method 2: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381002BDBM381002(1-(5-(tert-Butyl)-3-((dimethylphosphoryl)methoxy)-...)
Affinity DataIC50: 16nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381006BDBM381006(1-(3-(tert-Butyl)-5-(dimethylphosphoryl)phenyl)-3-...)
Affinity DataIC50: 16nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381146BDBM381146(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 17nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381158BDBM381158(3-((4-((4-(3-(5-(tert-Butyl)-3-((2-(dimethylamino)...)
Affinity DataIC50: 17nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381166BDBM381166(US9890185, Example 79(g))
Affinity DataIC50: 17nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381149BDBM381149(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 18nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381020BDBM381020(US9890185, Example 15(j))
Affinity DataIC50: 19nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381153BDBM381153(4-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Affinity DataIC50: 20nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381158BDBM381158(3-((4-((4-(3-(5-(tert-Butyl)-3-((2-(dimethylamino)...)
Affinity DataIC50: 20nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381126BDBM381126(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 21nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381102BDBM381102(US9890185, Example 38(y))
Affinity DataIC50: 21nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381134BDBM381134(3-((4-((4-(3-(3-(2-Amino-2-oxoethyl)-5-(tert-butyl...)
Affinity DataIC50: 22nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381068BDBM381068(1-(5-(tert-Butyl)-3-((dimethylphosphoryl)methyl)-2...)
Affinity DataIC50: 24nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381117BDBM381117(US9890185, Example 38(an))
Affinity DataIC50: 24nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381129BDBM381129(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Affinity DataIC50: 25nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381152BDBM381152(3-((4-((4-(3-(3-(Acetamidomethyl)-5-(tert-butyl)-2...)
Affinity DataIC50: 25nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381127BDBM381127(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Affinity DataIC50: 25nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381127BDBM381127(3-((4-((4-(3-(5-(tert-Butyl)-2-methoxy-3-(methylsu...)
Affinity DataIC50: 25nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381167BDBM381167(US9890185, Example 79(m))
Affinity DataIC50: 25nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381152BDBM381152(3-((4-((4-(3-(3-(Acetamidomethyl)-5-(tert-butyl)-2...)
Affinity DataIC50: 26nMAssay Description:Method 2: The inhibitory activities of compounds of the invention against p38MAPKγ (MAPK12: Invitrogen), are evaluated in a similar fashion to t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381075BDBM381075(1-(5-(tert-Butyl)-3-(dimethylphosphoryl)-2-methoxy...)
Affinity DataIC50: 27nMAssay Description:The inhibitory activities of compounds of the invention against c-Src and Syk enzymes (Invitrogen), are evaluated in a similar fashion to that descri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

TargetMitogen-activated protein kinase 14(Human)
Respivert

US Patent
LigandChemical structure of BindingDB Monomer ID 381080BDBM381080(US9890185, Example 38(c))
Affinity DataIC50: 27nMAssay Description:Method 1: The inhibitory activities of test compounds against the p38 MAPKα isoform (MAPK14: Invitrogen), are evaluated indirectly by determinin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2020
Entry Details
US Patent

Displayed 1 to 50 (of 468 total ) | Next | Last >>
Jump to: